1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6A57FE7631A19362800258C75002D748C
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-disease-awareness-program-cns-neurology-structure-timing?opendocument
18
19opendocument
2018.97.14.81
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Product Launch » Influences on Market Entry

Disease Awareness Program Excellence in CNS / Neurology: Structure and Timing

ID: 5869


Features:

4 Info Graphics

13 Data Graphics

280+ Metrics

3 Narratives


Pages/Slides: 24


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Disease Awareness Program Excellence in CNS / Neurology: Structure and Timing”

STUDY OVERVIEW

Awareness efforts in CNS/neurology are vital for spotlighting underdiagnosed conditions and guiding both HCPs and patients toward new treatment pathways. These campaigns play a key role in setting the stage for future product readiness.

Still, many companies struggle to effectively structure and time their campaigns in this nuanced therapeutic area, often missing opportunities for early engagement.

Best Practices, LLC conducted this study to identify how leading CNS-focused organizations are architecting and executing their disease awareness programs. This study presents benchmarks and lessons around program structure, optimal timing, and tactical deployment.


KEY TOPICS

  • CNS Disease Awareness Program Structure
  • Tactical Approaches for CNS Disease Awareness
  • Timing of Neurology Disease Awareness Activities

KEY METRICS

  • Organizational structure of CNS disease awareness programs – Total benchmark class, large vs. mid-small pharma; global vs. country level; single brand vs. portfolio
  • Functional leadership and cross-team collaboration in CNS disease awareness programs
  • Prevalence of dedicated CNS disease awareness teams
  • Initiation and conclusion points of CNS disease awareness resourcing – Total benchmark class, large vs. mid-small pharma; global vs. country level; single brand vs. portfolio; highly competitive vs. less competitive market
  • Timing and utilization of CNS disease awareness activities
  • Most frequent CNS disease awareness activities

SAMPLE KEY FINDINGS

  • Disease Awareness Activities: Unbranded websites, presentations or handouts, and disease information on advocacy websites are the most utilized disease awareness activities.

METHODOLOGY

Best Practices, LLC conducted this benchmarking research by engaging 9 leaders from 9 life sciences organizations specializing in CNS therapies. In addition to quantitative input, several participants shared deeper operational perspectives through one-on-one interviews. Relevant secondary research is incorporated to provide additional context.

Industries Profiled:
Pharmaceutical; Biotech; Manufacturing; Biopharmaceutical; Public Relations; Chemical; Health Care; Communications


Companies Profiled:
Adamas Pharmaceuticals; Biogen; Catalyst Pharmaceuticals; FleishmanHillard; Genentech; Genzyme; Indivior; Merck KGaA; NexGen Healthcare

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.